Offerings Archives - Page 11 of 166

3 minute read

Cidara Therapeutics Reacquires Global Development And Commercial Rights To CD388 From Johnson & Johnson For A One Time Payment Of $85M; Announces Private Placement Financing Of $240M

April 24, 4:47 PM

- $240 million private placement financing led by RA Capital Management with significant participation by Bain Capital Life Sciences as well as BVF Partners and Canaan Partners to fund Phase 2b clinical trial- CD388,

CDTX

2 minute read

Tantech Holdings Ltd Announces $2.1M Private Placement

By Benzinga Newsdesk

April 22, 3:59 PM

Tantech Holdings Ltd (NASDAQ:TANH) ("Tantech" or the "Company") today announced that it has entered into a securities purchase agreement with institutional investors to raise approximately $2.1 million in aggregate cash

TANH

2 minute read

Castor Maritime Inc. Announces Tender Offer To Purchase All Of Its 10,330,770 Outstanding Common Share Purchase Warrants Issued On April 7, 2021 At A Price Of $0.105 Per Warrant

By Benzinga Newsdesk

April 22, 9:14 AM

Castor Maritime Inc. (NASDAQ:CTRM), ("Castor" or the "Company"), a diversified global shipping company, announces that it has commenced today a tender offer (the "Offer") to purchase all of its 10,330,770 outstanding

CTRM

2 minute read

INmune Bio Inc. Raises ~$4.8M In Gross Proceeds Through Registered Direct Offering With Officers, Employees And Directors Purchasing ~20% Of The Offering

By Benzinga Newsdesk

April 22, 8:06 AM

INmune Bio, Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announced today that

INMB

2 minute read

Longeveron Raises A Total Of $11.4M In Gross Proceeds From Warrant Exercise Offering And Public Offering

By Benzinga Newsdesk

April 18, 4:09 PM

Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left

LGVN

1 minute read

Bio-Path Holdings Announces $1.2M Registered Direct Offering With Some Institutional Investors For Sale Of 375,000 Shares Of Its Common Stock At Price Of $3.225/Share

By Benzinga Newsdesk

April 18, 2:01 PM

Bio-Path Holdings, Inc., (NASDAQ:BPTH) (the "Company" or "Bio-Path"), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic

BPTH

1 minute read

Genetic Technologies Announces $2M Registered Direct Offering Of 1M ADS At A Price Of $2/ADS

By Benzinga Newsdesk

April 18, 12:18 PM

Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, ", Company", , ", GTG", , or ", Genetic Technologies", )), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, today

GENE

2 minute read

Zura Bio Announces Oversubscribed $112.5M Private Placement For 20.1M Class A Shares At A Price Of $3.108 Per Share; Financing Includes New And Existing Leading Life Sciences Institutional Investors; Strengthened Balance Sheet Expected To Fund Operati…

By Benzinga Newsdesk

April 18, 9:23 AM

- Financing includes new and existing leading life sciences institutional investors- Strengthened balance sheet expected to fund operations through 2027Zura Bio Limited (NASDAQ:ZURA) ("Zura Bio"), a clinical stage,

ZURA

3 minute read

On April 17, 2024, WiSa Technologies, Inc. Entered Into A $750K SPA With Certain Purchasers, Pursuant To Which The Company Agreed To Issue And Sell To Such Purchasers In A Registered Direct Offering, 225,834 Shares Of Common Stock, At An Offering Price…

By Benzinga Newsdesk

April 18, 8:53 AM

- SEC Filing On April 17, 2024, WiSA Technologies, Inc., a Delaware corporation (the "Company"), entered into a securities purchase agreement (the "Purchase Agreement") with certain purchasers, pursuant to

WISA

1 minute read

SuperCom Announces Pricing Of $2.9M Registered Direct Offering, The Combined Effective Purchase Price For One Ordinary Share And A Warrant To Purchase One Ordinary Share Will Be $0.36.

By Benzinga Newsdesk

April 18, 8:37 AM

SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, announced today that it has entered into a securities purchase agreement with a single institutional

SPCB